TY - JOUR AU - Darney, P. AU - Patel, A. AU - Rosen, K. AU - Shapiro, L. S. AU - Kaunitz, A. M. PY - 2009 DA - 2009// TI - Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials JO - Fertil Steril VL - 91 UR - https://doi.org/10.1016/j.fertnstert.2008.02.140 DO - 10.1016/j.fertnstert.2008.02.140 ID - Darney2009 ER - TY - BOOK PY - 2015 DA - 2015// TI - Trends in Contraceptive Use Worldwide 2015 ID - ref2 ER - TY - BOOK AU - Scoggins, S. AU - Bremner, J. PY - 2016 DA - 2016// TI - FP2020 Momentum at the Midpoint 2015–2016 Progress report ID - Scoggins2016 ER - TY - JOUR AU - Hohmann, H. PY - 2009 DA - 2009// TI - Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive JO - Patient Prefer Adherence VL - 3 UR - https://doi.org/10.2147/PPA.S4299 DO - 10.2147/PPA.S4299 ID - Hohmann2009 ER - TY - JOUR AU - Roberts, A. O. AU - Morhason-Bello, I. O. AU - Okunlola, M. A. PY - 2015 DA - 2015// TI - Profile of Implanon acceptors and pattern of side effects JO - J Reprod Contracept VL - 26 UR - https://doi.org/10.7669/j.issn.1001-7844.2015.01.0046 DO - 10.7669/j.issn.1001-7844.2015.01.0046 ID - Roberts2015 ER - TY - JOUR AU - Ojule, J. AU - Oranu, E. AU - Enyindah, C. PY - 2012 DA - 2012// TI - Experience with Implanon in Southern Nigeria JO - J Med Med Sci VL - 3 ID - Ojule2012 ER - TY - BOOK PY - 2015 DA - 2015// TI - Implanon NXT ® Product Information ID - ref7 ER - TY - JOUR AU - Creinin, M. D. AU - Kaunitz, A. M. AU - Darney, P. D. AU - Schwartz, L. AU - Hampton, T. AU - Gordon, K. PY - 2017 DA - 2017// TI - The US etonogestrel implant mandatory clinical training and active monitoring programs: 6-year experience JO - Contraception VL - 95 UR - https://doi.org/10.1016/j.contraception.2016.07.012 DO - 10.1016/j.contraception.2016.07.012 ID - Creinin2017 ER - TY - JOUR AU - Bitzer, J. AU - Tschudin, S. AU - Alder, J. PY - 2004 DA - 2004// TI - The Swiss Implanon Study Group the SIS. Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group JO - Eur J Contracept Reprod Heal Care VL - 9 UR - https://doi.org/10.1080/13625180400017503 DO - 10.1080/13625180400017503 ID - Bitzer2004 ER - TY - JOUR AU - Harrison-Woolrych, M. AU - Hill, R. PY - 2005 DA - 2005// TI - Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia JO - Contraception VL - 71 UR - https://doi.org/10.1016/j.contraception.2004.10.005 DO - 10.1016/j.contraception.2004.10.005 ID - Harrison-Woolrych2005 ER - TY - BOOK AU - Lince-Deroche, N. AU - Pleaner, M. AU - Harries, J. AU - Morroni, C. AU - Mullick, S. AU - Firnhaber, C. PY - 2016 DA - 2016// TI - Achieving universal access to sexual and reproductive health services: the potential and pitfalls for contraceptive services in South Africa ID - Lince-Deroche2016 ER - TY - JOUR AU - Patel, R. C. AU - Onono, M. AU - Gandhi, M. AU - Blat, C. AU - Hagey, J. AU - Shade, S. B. PY - 2015 DA - 2015// TI - Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study JO - Lancet HIV VL - 2 UR - https://doi.org/10.1016/S2352-3018(15)00184-8 DO - 10.1016/S2352-3018(15)00184-8 ID - Patel2015 ER - TY - BOOK PY - 2015 DA - 2015// TI - Transforming our world: the 2030 agenda for sustainable development ID - ref13 ER - TY - STD TI - Republic of South Africa National Department of Health. National Contraception Clinical Guidelines 2012. Pretoria: Department of Health; 2013. ID - ref14 ER - TY - BOOK PY - 2016 DA - 2016// TI - B.V. IMPLANON® (etonogestrel implant) FDA approved labelling ID - ref15 ER - TY - JOUR AU - Colquhoun, H. L. AU - Levac, D. AU - O’Brien, K. K. AU - Straus, S. AU - Tricco, A. C. AU - Perrier, L. PY - 2014 DA - 2014// TI - Scoping reviews: time for clarity in definition, methods, and reporting JO - J Clin Epidemiol VL - 67 UR - https://doi.org/10.1016/j.jclinepi.2014.03.013 DO - 10.1016/j.jclinepi.2014.03.013 ID - Colquhoun2014 ER - TY - JOUR AU - Arksey, H. AU - O ‘malley, L. PY - 2005 DA - 2005// TI - Scoping studies: towards a methodological framework JO - Int J Soc Res Methodol VL - 8 UR - https://doi.org/10.1080/1364557032000119616 DO - 10.1080/1364557032000119616 ID - Arksey2005 ER - TY - JOUR AU - Davies, K. S. PY - 2011 DA - 2011// TI - Formulating the evidence based practice question: a review of the frameworks JO - Evid Based Libr Inf Pract VL - 6 UR - https://doi.org/10.18438/B8WS5N DO - 10.18438/B8WS5N ID - Davies2011 ER - TY - JOUR AU - Castleberry, A. PY - 2014 DA - 2014// TI - NVivo 10 [software program]. Version 10. QSR International; 2012 JO - Am J Pharm Educ VL - 78 UR - https://doi.org/10.5688/ajpe78125 DO - 10.5688/ajpe78125 ID - Castleberry2014 ER - TY - JOUR AU - Pluye, P. AU - Robert, E. AU - Cargo, M. AU - Bartlett, G. PY - 2011 DA - 2011// TI - Proposal: a mixed methods appraisal tool for systematic mixed studies reviews JO - Montréal McGill Univ VL - Part I ID - Pluye2011 ER - TY - JOUR AU - Ezegwui, H. U. AU - Ikeako, L. C. AU - Ishiekwene, C. I. C. AU - Oguanua, T. C. PY - 2010 DA - 2010// TI - The discontinuation rate and reasons for discontinuation of Implanon at the family planning clinic of University of Nigeria Teaching Hospital (UNTH) Enugu, Nigeria JO - Niger J Med VL - 20 ID - Ezegwui2010 ER - TY - JOUR AU - Mukherjee, S. AU - Sen, S. AU - Kelaiselvan, V. AU - Tripathi, S. PY - 2016 DA - 2016// TI - Consumer reporting of adverse drug reactions JO - Int J Green Pharm VL - 10 UR - https://doi.org/10.15252/embr.201642616 DO - 10.15252/embr.201642616 ID - Mukherjee2016 ER -